Dr. Julio Cesar Delgado, MD

Dr. Delgado practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Delgado's NPI, 1689621948, was assigned on May 30, 2006. Dr. Delgado holds Utah license 6234516-1205.

Dr. Delgado's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Delgado's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Delgado is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Delgado to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Delgado practices, 3 sites in all. Vendor and product names are available with a free account.

Medical genetics is Dr. Delgado's primary specialty in the NPI Registry, under taxonomy code 207SM0001X. The record also lists molecular genetic pathology. Dr. Delgado is licensed in Utah.

CMS data shows 1,214 Medicare services from Dr. Delgado across 3 procedure codes in 2024, for 723 Medicare patients. Medicare paid $15,748 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 723 Medicare patients who saw Dr. Delgado in 2024. The largest group is 65 to 74, with 371 patients. 74% of them have high blood pressure, and 61% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Delgado's median patient age at 72, with 47% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Delgado for performance year 2024, reported as part of a group. Dr. Delgado accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 58 papers to Dr. Delgado, published from 2008 to 2025. 2016 was the busiest year, with 4. The most frequent topics are COVID-19, Histocompatibility Testing and SARS-CoV-2. Dr. Delgado has published most often in J Appl Lab Med. Dr. Delgado's most frequent co-authors are Peter E. Jensen, MD, Adam Mitchell Spivak, MD and Harry R. Hill, MD.

Dmand AI links Dr. Delgado to 1 clinical trial.

CMS Open Payments shows 8 general payments to Dr. Delgado from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Immucor, Inc. paid the most, $92.